Bruce W Bode Selected Research

Sodium-Glucose Transporter 1

9/2018

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce W Bode Research Topics

Disease

45	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024 - 05/2005
45	Hypoglycemia (Reactive Hypoglycemia) 11/2023 - 01/2002
19	Type 2 Diabetes Mellitus (MODY) 05/2023 - 09/2003
13	Hyperglycemia 10/2022 - 10/2005
9	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2023 - 07/2013
7	Body Weight (Weight, Body) 01/2021 - 07/2011
5	Weight Gain 10/2018 - 01/2002
4	Weight Loss (Weight Reduction) 12/2020 - 07/2015
4	Critical Illness (Critically Ill) 01/2017 - 03/2004
2	Infections 09/2018 - 01/2016
2	Diabetes Mellitus 01/2007 - 11/2002
1	Diarrhea 09/2018
1	Nausea 02/2017
1	Obesity 02/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2016
1	Cough 12/2015
1	Insulin Resistance 01/2013
1	Body Weight Changes 12/2011
1	Ketosis 06/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2009
1	Inflammation (Inflammations) 01/2007
1	Pain (Aches) 01/2007
1	Myocardial Infarction 03/2004

Drug/Important Bio-Agent (IBA)

54	Insulin (Novolin)FDA Link 02/2024 - 05/2002
36	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 05/2005
11	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 08/2005
11	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2004
11	Insulin Aspart (NovoLog)FDA Link 01/2019 - 09/2003
6	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2023 - 09/2009
6	Insulin Lispro (Humalog)FDA Link 05/2023 - 05/2005
6	Hemoglobins (Hemoglobin)IBA 01/2020 - 08/2010
4	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021 - 07/2015
4	insulin degludecIBA 01/2019 - 08/2014
3	Sodium-Glucose Transport ProteinsIBA 06/2019 - 07/2015
3	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2018 - 07/2015
3	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2016 - 12/2011
3	Insulin Glargine (Lantus)FDA Link 08/2015 - 03/2005
2	Glucagon Receptors (Glucagon Receptor)IBA 11/2023 - 10/2022
2	volagidemabIBA 11/2023 - 10/2022
2	Glucagon (Glukagon)FDA Link 10/2022 - 01/2013
2	Sitagliptin Phosphate (Januvia)FDA Link 12/2020 - 01/2013
2	Liraglutide FDA Link 02/2017 - 12/2011
2	Metformin (Glucophage)FDA LinkGeneric 02/2016 - 07/2011
2	Dipeptidyl-Peptidase IV InhibitorsIBA 02/2016 - 01/2013
2	InsulinsIBA 01/2016 - 01/2007
2	SuspensionsIBA 05/2015 - 07/2013
2	C-PeptideIBA 10/2014 - 01/2013
2	Short-Acting InsulinIBA 01/2007 - 01/2002
1	Transaminases (Aminotransferases)IBA 10/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2022
1	LDL CholesterolIBA 10/2022
1	semaglutideIBA 12/2020
1	monoclonal antibody RN168IBA 12/2019
1	Interleukin-7 (Interleukin 7)IBA 12/2019
1	Sodium-Glucose Transporter 1IBA 09/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2017
1	IDegLiraIBA 02/2017
1	DiamondIBA 01/2017
1	empagliflozinIBA 02/2016
1	otelixizumabIBA 10/2014
1	Monoclonal AntibodiesIBA 10/2014
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2013
1	gamma-glutamylaspartic acidIBA 06/2011
1	insulin glulisine FDA Link 06/2011
1	IncretinsIBA 09/2009

Therapy/Procedure

32	Therapeutics 01/2023 - 01/2002
24	Glycemic Control 11/2023 - 01/2002
10	Injections 01/2023 - 01/2002
1	Protective Devices (Safety Device) 01/2016
1	Intramuscular Injections 01/2016
1	Drug Tapering 07/2015
1	Catheters 06/2011
1	Critical Care (Surgical Intensive Care) 03/2004